12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Biological Insights Into Muscular Strength: Genetic Findings in the UK Biobank

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We performed a large genome-wide association study to discover genetic variation associated with muscular strength, and to evaluate shared genetic aetiology with and causal effects of muscular strength on several health indicators. In our discovery analysis of 223,315 individuals, we identified 101 loci associated with grip strength ( P <5 × 10 −8). Of these, 64 were associated ( P < 0.01 and consistent direction) also in the replication dataset (N = 111,610). eQTL analyses highlighted several genes known to play a role in neuro-developmental disorders or brain function, and the results from meta-analysis showed a significant enrichment of gene expression of brain-related transcripts. Further, we observed inverse genetic correlations of grip strength with cardiometabolic traits, and positive correlation with parents’ age of death and education. We also showed that grip strength had shared biological pathways with indicators of frailty, including cognitive performance scores. By use of Mendelian randomization, we provide evidence that higher grip strength is protective of both coronary heart disease (OR = 0.69, 95% CI 0.60–0.79, P < 0.0001) and atrial fibrillation (OR = 0.75, 95% CI 0.62–0.90, P = 0.003). In conclusion, our results show shared genetic aetiology between grip strength, and cardiometabolic and cognitive health; and suggest that maintaining muscular strength could prevent future cardiovascular events.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Hand grip strength: outcome predictor and marker of nutritional status.

          Among all muscle function tests, measurement of hand grip strength has gained attention as a simple, non-invasive marker of muscle strength of upper extremities, well suitable for clinical use. This review outlines the prognostic relevance of grip strength in various clinical and epidemiologic settings and investigates its suitability as marker of nutritional status in cross-sectional as well as intervention studies. Studies investigating grip strength as prognostic marker or nutritional parameter in cross-sectional or intervention studies were summarized. Numerous clinical and epidemiological studies have shown the predictive potential of hand grip strength regarding short and long-term mortality and morbidity. In patients, impaired grip strength is an indicator of increased postoperative complications, increased length of hospitalization, higher rehospitalisation rate and decreased physical status. In elderly in particular, loss of grip strength implies loss of independence. Epidemiological studies have moreover demonstrated that low grip strength in healthy adults predicts increased risk of functional limitations and disability in higher age as well as all-cause mortality. As muscle function reacts early to nutritional deprivation, hand grip strength has also become a popular marker of nutritional status and is increasingly being employed as outcome variable in nutritional intervention studies. Copyright © 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neural adaptation to resistance training.

            D G Sale (1988)
            Strength performance depends not only on the quantity and quality of the involved muscles, but also upon the ability of the nervous system to appropriately activate the muscles. Strength training may cause adaptive changes within the nervous system that allow a trainee to more fully activate prime movers in specific movements and to better coordinate the activation of all relevant muscles, thereby effecting a greater net force in the intended direction of movement. The evidence indicating neural adaptation is reviewed. Electromyographic studies have provided the most direct evidence. They have shown that increases in peak force and rate of force development are associated with increased activation of prime mover muscles. Possible reflex adaptations related to high stretch loads in jumping and rapid reciprocal movements have also been revealed. Other studies, including those that demonstrate the "cross-training" effect and specificity of training, provide further evidence of neural adaptation. The possible mechanisms of neural adaptation are discussed in relation to motor unit recruitment and firing patterns. The relative roles of neural and muscular adaptation in short- and long-term strength training are evaluated.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence

              Intelligence is associated with important economic and health-related life outcomes 1 . Despite substantial heritability 2 (0.54) and confirmed polygenic nature, initial genetic studies were mostly underpowered 3–5 . Here we report a meta-analysis for intelligence of 78,308 individuals. We identify 336 single nucleotide polymorphisms (SNPs) (METAL P 500,000 participants. All participants provided written informed consent; the UK Biobank received ethical approval from the National Research Ethics Service Committee North West–Haydock (reference 11/NW/0382), and all study procedures were performed in accordance with the World Medical Association Declaration of Helsinki ethical principles for medical research. The current study was conducted under the UK Biobank application number 16406. The study design of the UK Biobank has been described in detail elsewhere 35,36 . Briefly, invitation letters were sent out in 2006–2010 to ~9.2 million individuals including all people aged 40–69 years who were registered with the National Health Service and living up to ~25 miles from one of the 22 study assessment centers. A total of 503,325 participants were subsequently recruited into the study 35 . Apart from registry based phenotypic information, extensive self-reported baseline data have been collected by questionnaire, in addition to anthropometric assessments and DNA collection. For the present study we used imputed data obtained from UK Biobank (May 2015 release) including ~73 million genetic variants in 152,249 individuals. Details on the data are provided elsewhere (see URLs). In summary, the first ~50,000 samples were genotyped on the UK BiLEVE Axiom array, and the remaining ~100,000 samples were genotyped on the UK Biobank Axiom array. After standard quality control of the SNPs and samples, which was centrally performed by UK Biobank, the dataset comprised 641,018 autosomal SNPs in 152,256 samples for phasing and imputation. Imputation was performed with a reference panel that included the UK10K haplotype panel and the 1000 Genomes Project Phase 3 reference panel. We used two fluid intelligence phenotypes from the Biobank data set. These are based on questionnaires that were taken either in the assessment center at the initial intake (‘touchscreen’, field 20016) or at a later moment at home (‘web-based’, field 20191). The measures indicate the number of correct answers out of 13 fluid intelligence questions. The data distribution roughly approximates a normal distribution. For the analyses in our study, we only included individuals of Caucasian descent. After removal of related individuals, discordant sex, withdrawn consent, and missing phenotype data, 36,257 individuals remained for analysis for the fluid intelligence touchscreen measure and 28,846 for the web-based version. As 10,984 individuals had taken both the touchscreen and the web-based test, we only included the data from the touchscreen test for these individuals. This resulted in 54,119 individuals with a score on either the fluid intelligence web-based (UKB-wb) or touchscreen (UKB-ts) version (Supplementary Table 1). At the time of taking the test, participants’ ages ranged between 40 and 78. Half of the participants were between 40 and 60 years old, 44% between 60 and 70 and 6% were older than 70. The mean age was 58.98 with a standard deviation of 8.19. Summary statistics from CHIC consortium We downloaded the publicly available combined GWAS results from the meta-analyses as reported by CHIC 5 (see URLs). Details on the included cohorts and performed analyses are reported in the original publication 5 . Briefly, CHIC includes 6 cohorts totaling 12,441 individuals: the Avon Longitudinal Study of Parents and Children (ALSPAC, N = 5,517), the Lothian Birth Cohorts of 1921 and 1936 (LBC1921, N = 464; LBC1936, N = 947), the Brisbane Adolescent Twin Study subsample of Queensland Institute of Medical Research (QIMR, N = 1,752), the Western Australian Pregnancy Cohort Study (Raine, N = 936), and the Twins Early Development Study (TEDS, N = 2,825). All individuals are children aged between 6–18 years. Within each cohort the cognitive performance measure was adjusted for sex and age and principal components were included to adjust for population stratification. See also Supplementary Table 1. Full GWAS data from additional cohorts We used the same additional (non-CHIC) cohorts as described in detail in ref. 7 , which included 11,748 individuals from 5 cohorts. In ref. 7 , results were only reported for 69 SNPs, as these served as a secondary analysis for a look-up effort. In the current study we use the full genome-wide results from these cohorts. GWAS were conducted in 2013 and summary statistics were obtained from the PIs of the 5 cohorts. The quality control protocol entailed excluding SNPs with MAF 0.01. Positional annotations for all lead SNPs and SNPs in LD with the lead SNPs were obtained by performing ANNOVAR gene-based annotation using refSeq genes. In addition, CADD scores 38 , and RegulomeDB 15 scores were annotated to SNPs by matching chromosome, position, reference and alternative alleles. For each SNP eQTLs were extracted from GTEx (44 tissue types) 39 , Blood eQTL browser 40 and BIOS gene-level eQTLs 41 . The eQTLs obtained from GTEx were filtered on gene P-value < 0.05 and eQTLs obtained from the other two databases were filtered on FDR < 0.05. The FDR values were provided by GTEx, BIOS and Blood eQTL browser. For GTEx eQTLs, there is one FDR value available per gene-tissue pair. As such, the FDR is identical for all eQTLs belonging to the same gene-tissue pair. For BIOS and Blood eQTL browser, an FDR value was computed per SNP. To test whether the SNPs were functionally active by means of histone modifications, we obtained epigenetic data from the NIH Roadmap Epigenomics Mapping Consortium 42 and ENCODE 43 . For every 200bp of the genome a 15-core chromatin state was predicted by a Hidden Markov Model based on 5 histone marks (i.e. H3K4me3, H3K4me1, H3K27me3, H3K9me3, and H3K36me3) for 127 tissue/cell types 44 . We annotated chromatin states (15 states in total) to SNPs by matching chromosome and position for every tissue/cell type. We computed the minimum state (1: the most active state) and the consensus state (majority of states) across 127 tissue/cell types for each SNP. Chromatin states were also determined for the 52 genes (47 from the gene-based test + 5 additional genes implicated by single SNP GWAS). For each gene and tissue, the chromatin state was obtained per 200 bp interval in the gene. We then annotated the genes by means of a consensus decision when multiple states were present for a single gene; i.e. the state of the gene was defined as the modus of all states present in the gene. Tissue expression of genes RNA sequencing data of 1,641 tissue samples with 45 unique tissue labels was derived from the GTEx consortium 39 . This set includes 313 brain samples over 13 unique brain regions (see Supplementary Table 18 for sample size per tissue). Of the 52 genes implicated by either the GWAS or the GWGWAS, 44 were included in the GTEx data. Normalization of the data was performed as described previously 45 . Briefly, genes with RPKM (Reads Per Kilobase Million) value smaller than 0.1 in at least 80% of the samples were removed. The remaining genes were log2 transformed (after using a pseudocount of 1), and finally a zero-mean normalization was applied. Proxy-replication in educational attainment For the replication analysis we used a subset of the data from ref. 21. In particular, we excluded the Erasmus Rucphen Family, the Minnesota Center for Twin and Family Research Study, the Swedish Twin Registry Study, the 23andMe data and all individuals from UK Biobank, to make sure there was no sample overlap with our IQ dataset. Genetic correlation between intelligence and EA in this non-overlapping subsample was rg=0.73, SE=0.03, P=1.4×10−163. The replication analysis was based on the phenotype EduYears, which measures the number of years of schooling completed. A total of 306 out of our 336 top SNPs (and 16 out of 18 independent lead SNPs) was available in the educational attainment sample. We performed a sign concordance analysis for the 16 independent lead SNPs, using the exact binomial test. For each independent signal we determined whether either the lead SNP had a P-value smaller than 0.05/16 in the educational attainment analysis, or another (correlated) top SNP in the same locus if this was not the case. All 47 genes implicated in the GWGAS for intelligence were available for look-up in the EA sample. For each gene we determined whether it had a P-value smaller than 0.05/47 in the EA analysis. Polygenic Risk Score analysis We used LDpred 16 to calculate the variance explained in intelligence in independent samples by a polygenic risk score based on our discovery analysis, as well as based on two previous GWAS studies for intelligence 5,6 . LDpred adjusts GWAS summary statistics for the effects of linkage disequilibrium (LD) by using an approximate Gibbs sampler that calculates posterior means of effects, conditional on LD information, when calculating polygenic risk scores. We used varying priors for the fraction of SNPs with non-zero effects (prior: 0.01, 0.05, 0.1, 0.5, 1, and an infinitesimal prior). Independent datasets available for PRS analyses are described in the Supplementary Note. Supplementary Material 1 2 3 4
                Bookmark

                Author and article information

                Contributors
                eriking@stanford.edu
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                24 April 2018
                24 April 2018
                2018
                : 8
                : 6451
                Affiliations
                [1 ]ISNI 0000000419368956, GRID grid.168010.e, Division of Cardiovascular Medicine, Department of Medicine, , Stanford University School of Medicine, ; Stanford, CA USA
                [2 ]ISNI 0000 0004 1936 9457, GRID grid.8993.b, Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, , Uppsala University, ; Uppsala, Sweden
                [3 ]ISNI 0000000419368956, GRID grid.168010.e, Stanford Cardiovascular Institute, , Stanford University, ; Stanford, CA 94305 USA
                Author information
                http://orcid.org/0000-0001-9418-9577
                Article
                24735
                10.1038/s41598-018-24735-y
                5915424
                29691431
                65ab3d4e-3557-44f7-9688-2802f1fda5a2
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 14 December 2017
                : 10 April 2018
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article